N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin

Journal of Investigative Dermatology

Volumn 111, Issue 5, 1998, Pages 757-761

  Jiveskog, Sofia ^a   Ragnarsson Olding, Boel ^a   Platz, Anton ^a   Ringborg, Ulrik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Human melanoma; Mutation analysis; Ras genes; UV exposure

Indexed keywords

DNA; ONCOPROTEIN;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HEAD AND NECK TUMOR; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MUCOSA; NUCLEOTIDE SEQUENCE; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SUN EXPOSURE; TUMOR LOCALIZATION; VULVA TUMOR;

EID: 0031738326     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00376.x     Document Type: Article

References (27)

1. Albino AP, Nanus DM, Mentle IR, Cordon-Cardo C, McNutt NS, Bressler J, Andreeff M: Analysis of ras oncogenes in malignant melanoma and precursor lesions correlation of point mutations with differentiation phenotype. Oncogene 4:1363-1374, 1989
2. Anders F: Contributions of the Gordon-Kosswig melanoma system to the present concept of neoplasia. Pregment Cell Res 4:7-29, 1991
3. Ball NJ, Yohn JJ, Morelli JG, Norris DA, Golitz LE, Hoeffler JP: ras mutations in human melanoma a marker of malignant progression. J Invest Dermatol 102:285-290, 1994
4. Barbacid M: ras genes. Annu Rev Biochem 56:779-827, 1978
5. Bos JL: ras oncogenes in human cancer: a review. Cancer Res 49:4682-4689, 1989
6. Carr J, Mackie RM: Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. Br J Dermatol 131:72-77, 1994
7. van Elsas A, Zerp SF, van der Flier S, et al: Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am J Pathol 149:883-893, 1996
8. Jafari M, Papp T, Kirchner S, Diener U, Henschler D, Burg C, Schiffmann D: Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma. J Cancer Res Clin Oncol 121:23-30, 1995
9. Ley RD: Ultraviolet radiation A-induced precursors of cutaneous melanoma in Monodelphis domestica. Cancer Res 57:3682-3684, 1997
10. Ley RD, Applegate LA, Padilla RS, Stuart TD: Ultraviolet radiation-induced malignant melanoma in Monodelphis domestica. Photochem Photobiol 50:1-5, 1989
11. Longstreth JD, Lea CS, Kripke ML: Ultraviolet radiation and other putative causes of melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S (eds). Cutaneous Melanoma. Philadelphia: Lippincott, 1992, pp. 46-58
12. van der Lubbe JLM, Rosdorff HJM, Bos JL, van der Eb AJ: Activation of N-ras induced by ultraviolet irradiation in vitro. Oncogene Res 3:9-20, 1988
13. MacLennan R, Green AC, McLeod GRC, Martin NG: Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 84:1427-1432, 1992
14. Mehta CR, Patel NR, Tsiatis AA: Exact significance testing to establish treatment equivalence for ordered categorical data. Biometrics 40:819-825, 1984
15. Pierceall WE, Kripke ML, Ananthaswamy HN: N-ras mutation in ultraviolet radiation-induced murine skin cancers. Cancer Res 52: 3946-3951, 1992
16. Platz A, Ringborg U, Mansson Brahme E, Lagerlöf B: Melanoma metastases from patients with hereditary cutaneous malignant melanoma contain a high frequency of N-ras activating mutations. Melanoma Res 4:169-177, 1994
17. Platz A, Ringborg U, Grafström E, Höög A, Lagerlöf B: Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumors and metastases of human malignant melanoma: increased immunopositivity in hereditary melanoma. Melanoma Res 5:101-106, 1995a
18. Platz A, Grafström E, Lagerlöf B, Mannervik B, Ringborg U: Glutathione transterase expression in human malignant melanoma metastases: correlation to N-ras mutation and expression. Acta Oncol 34:759-765, 1995b
19. 1 checkpoint control are frequently mutated in human melanoma metastases. Br J Cancer 74:936-941, 1996
20. Ragnarsson-Olding B, Johansson H, Rutqvist I.-E, Ringborg U: Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution and long-term survival among 245 consecutive cases in Sweden 1960-84. Cancer 71:1893-1897, 1993
21. Raybaud F, Noguchi T, Maries I, et al: Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay. Cancer Res 48:950-953, 1988
22. Setlow RB, Woodhead AD, Grist E: Animal model for ultraviolet radiation-induced melanoma: platyfish-swordtail hybrid. Proc Natl Acad Sci USA 86:8922-8926, 1989
23. Shukla VK, Hughes LE, McCormick F, Padua RA: ras mutations in human melanocytic lesions: K-ras activation is a frequent and early event in melanoma development. Oncogene Res 5:121-127, 1989
24. Thörn M, Adami H-O, Ringborg U, Bergström R, Krusemo UB: The association between anatomic site and survival in malignant melanoma. An analysis of 12, 353 cases from the Swedish Cancer Registry. Eur J Cancer Clin Oncol 25:483-491, 1989
25. Törmänen VT, Pfeifer GP: Mapping of UV photoproducts within ras proto-oncogenes in UV-irradiated cells: correlation with mutations in human skin cancer. Oncogene 7:1729-1736, 1992
26. van't Veer LJ, Burgering BMT, Versteeg R, et al: N-ras mutations in human cutaneous melanoma on sun-exposed body sites. Mol Cell Biol 9:3114-3116, 1989
27. Yamamoto F, Nishimura S, Kasai H: Photosensitized formation of 8-hydroxydeoxyguanosine in cellular DNA by riboflavin. Biochem Biophys Res Commun 187:809-813, 1992